SPON1 and ovarian carcinoma: To investigate whether SPON1-TRIM29 expression substantially modulates cell proliferation and drug sensitivity in ovarian cancer cells, we designed siRNAs spanning the fusion sequence of SPON1-TRIM29 (siFusion #A and #B) to specifically silence the SPON1-TRIM29 fusion gene.